NCT01010100View on ClinicalTrials.gov

Prevent/Delay Development of Type 2 Diabetes in Subjects With Impaired Glucose Homeostasis Treated With Acarbose in Primary Care

PHASE3CompletedINTERVENTIONAL
Enrollment

204

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Diabetes Mellitus
Interventions
DRUG

Acarbose (Glucobay, BAYG5421)

50 mg TID

DRUG

Placebo

50 mg TID

Trial Locations (23)

24010

Trobajo del Camino

27373

Begonte

27800

Villalba

28033

Madrid

41900

Camas

43005

Tarragona

43006

Tarragona

43120

Constantí

43201

Reus

43202

Reus

43203

Reus

43350

les Borges del Camp

43360

Cornudella

43500

Tortosa

43729

Vinebre

43730

Falset

43760

el Morell

03698

Agost

03007

Alicante

Unknown

Crevillent

03660

Novelda

03690

San Vicent del Raspeig

08223

Terrassa

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY